Market Tracker

07/31 1:36pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

36.36
Data as of 1:21pm ET
 -0.36 / -0.98%
Today’s Change
20.02
Today|||52-Week Range
42.50
+73.31%
Year-to-Date

Today’s Trading

Previous close36.72
Today’s open36.42
Day’s range35.80 - 37.33
Volume181,767
Average volume (3 months)1,070,217
Market cap$2.7B
Dividend yield--
Data as of 1:21pm ET, 07/31/2014

Growth & Valuation

Earnings growth (last year)+36.15%
Earnings growth (this year)+35.98%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+23.62%
P/E ratio15.5
Price/Sales3.55
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc-0.33-1.50%
NPSPNPS Pharmaceuticals ...-1.04-3.55%
WXWuXi Pharmatech (Cay...-0.62-1.95%
MNKDMannkind Corp-0.22-2.52%
Data as of 1:21pm ET, 07/31/2014

Financials

Next reporting dateAugust 12, 2014
EPS forecast (this quarter)$0.46
Annual revenue (last year)$613.2M
Annual profit (last year)$147.1M
Net profit margin24.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts